Insider · CIK 0001779308
Catriona Yale
officer
Files at AKRO (Akero Therapeutics, Inc.). First filing Oct 16, 2024, latest Mar 18, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 11
$0 bought, $9.0M sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Side | Company | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 12Weak | sell 610b5-1 | AKRO Akero Therapeutics, Inc. | $448k | 10,000 | -10% | - | |
| 35Weak | sell 6 | AKRO Akero Therapeutics, Inc. | $28k | 614 | -1% | - | |
| 13Weak | sell 510b5-1 | AKRO Akero Therapeutics, Inc. | $499k | 10,000 | -9% | - | |
| 30Weak | sell 510b5-1 | AKRO Akero Therapeutics, Inc. | $2.7M | 49,074 | -34% | - | |
| 30Weak | sell 510b5-1 | AKRO Akero Therapeutics, Inc. | $3.0M | 53,590 | -36% | - | |
| 8Weak | sell 610b5-1 | AKRO Akero Therapeutics, Inc. | $264k | 9,074 | -9% | - | |
| 39Weak | sell 6 | AKRO Akero Therapeutics, Inc. | $87k | 2,810 | -4% | - | |
| 13Weak | sell 310b5-1 | AKRO Akero Therapeutics, Inc. | $251k | 9,061 | -11% | - | |
| 15Weak | sell 310b5-1 | AKRO Akero Therapeutics, Inc. | $352k | 10,000 | -12% | - | |
| 25Weak | sell 310b5-1 | AKRO Akero Therapeutics, Inc. | $652k | 20,000 | -25% | - | |
| 25Weak | sell 310b5-1 | AKRO Akero Therapeutics, Inc. | $636k | 20,961 | -26% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 17, 2025 | AKRO Akero Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +10,000 | $21.10 | $211k | 105,034 | Mar 18, 2025 |
| Mar 17, 2025 | AKRO Akero Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -8,201 | $44.70 | $367k | 96,833 | Mar 18, 2025 |
| Mar 17, 2025 | AKRO Akero Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,799 | $45.05 | $81k | 95,034 | Mar 18, 2025 |
| Mar 17, 2025 | AKRO Akero Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -10,000 | $0.00 | $0 | 0 | Mar 18, 2025 |
| Mar 12, 2025 | AKRO Akero Therapeutics, Inc. | SOpen-market sale Common Stock | -614 | $44.88 | $28k | 95,034 | Mar 14, 2025 |
| Feb 18, 2025 | AKRO Akero Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +10,000 | $21.10 | $211k | 105,648 | Feb 21, 2025 |
| Feb 18, 2025 | AKRO Akero Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -9,100 | $49.79 | $453k | 96,548 | Feb 21, 2025 |
| Feb 18, 2025 | AKRO Akero Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -900 | $50.63 | $46k | 95,648 | Feb 21, 2025 |
| Feb 18, 2025 | AKRO Akero Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -10,000 | $0.00 | $0 | 10,000 | Feb 21, 2025 |
| Jan 27, 2025 | AKRO Akero Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +49,074 | $21.10 | $1.0M | 144,722 | Jan 31, 2025 |
| Jan 27, 2025 | AKRO Akero Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +16,849 | $0.62 | $10k | 112,497 | Jan 31, 2025 |
| Jan 27, 2025 | AKRO Akero Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -25,907 | $55.15 | $1.4M | 118,815 | Jan 31, 2025 |
| Jan 27, 2025 | AKRO Akero Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +15,172 | $6.36 | $97k | 127,669 | Jan 31, 2025 |
| Jan 27, 2025 | AKRO Akero Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -14,467 | $55.95 | $809k | 104,348 | Jan 31, 2025 |
| Jan 27, 2025 | AKRO Akero Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +21,569 | $21.09 | $455k | 149,238 | Jan 31, 2025 |
| Jan 27, 2025 | AKRO Akero Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -8,700 | $57.01 | $496k | 95,648 | Jan 31, 2025 |
| Jan 27, 2025 | AKRO Akero Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -17,000 | $55.16 | $938k | 132,238 | Jan 31, 2025 |
| Jan 27, 2025 | AKRO Akero Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -20,000 | $0.00 | $0 | 33,421 | Jan 31, 2025 |
| Jan 27, 2025 | AKRO Akero Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -9,250 | $55.95 | $518k | 122,988 | Jan 31, 2025 |
| Jan 27, 2025 | AKRO Akero Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -20,000 | $0.00 | $0 | 0 | Jan 31, 2025 |
| Jan 27, 2025 | AKRO Akero Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -27,340 | $57.02 | $1.6M | 95,648 | Jan 31, 2025 |
| Jan 27, 2025 | AKRO Akero Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -9,074 | $0.00 | $0 | 20,000 | Jan 31, 2025 |
| Jan 27, 2025 | AKRO Akero Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -16,849 | $0.00 | $0 | 0 | Jan 31, 2025 |
| Jan 27, 2025 | AKRO Akero Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -15,172 | $0.00 | $0 | 0 | Jan 31, 2025 |
| Jan 27, 2025 | AKRO Akero Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -641 | $0.00 | $0 | 0 | Jan 31, 2025 |
| Jan 27, 2025 | AKRO Akero Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -20,928 | $0.00 | $0 | 52,785 | Jan 31, 2025 |
| Dec 16, 2024 | AKRO Akero Therapeutics, Inc. | AGrant or award Common Stock10b5-1 | +24,300 | $0.00 | $0 | 95,648 | Dec 18, 2024 |
| Dec 16, 2024 | AKRO Akero Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +9,074 | $21.10 | $191k | 104,722 | Dec 18, 2024 |
| Dec 16, 2024 | AKRO Akero Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -9,074 | $29.11 | $264k | 95,648 | Dec 18, 2024 |
| Dec 16, 2024 | AKRO Akero Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -9,074 | $0.00 | $0 | 20,000 | Dec 18, 2024 |
| Dec 16, 2024 | AKRO Akero Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative10b5-1 | +73,700 | $0.00 | $0 | 73,700 | Dec 18, 2024 |
| Dec 10, 2024 | AKRO Akero Therapeutics, Inc. | SOpen-market sale Common Stock | -2,810 | $30.79 | $87k | 71,348 | Dec 12, 2024 |
| Nov 15, 2024 | AKRO Akero Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +9,061 | $21.10 | $191k | 83,219 | Nov 19, 2024 |
| Nov 15, 2024 | AKRO Akero Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -8,761 | $27.69 | $243k | 74,458 | Nov 19, 2024 |
| Nov 15, 2024 | AKRO Akero Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -300 | $28.82 | $8,647 | 74,158 | Nov 19, 2024 |
| Nov 15, 2024 | AKRO Akero Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -9,061 | $0.00 | $0 | 53,421 | Nov 19, 2024 |
| Nov 6, 2024 | AKRO Akero Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +10,000 | $0.62 | $6,150 | 84,158 | Nov 8, 2024 |
| Nov 6, 2024 | AKRO Akero Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -10,000 | $35.19 | $352k | 74,158 | Nov 8, 2024 |
| Nov 6, 2024 | AKRO Akero Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -8,890 | $0.00 | $0 | 0 | Nov 8, 2024 |
| Nov 6, 2024 | AKRO Akero Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,110 | $0.00 | $0 | 16,849 | Nov 8, 2024 |
| Oct 30, 2024 | AKRO Akero Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +4,515 | $21.10 | $95k | 78,673 | Nov 1, 2024 |
| Oct 30, 2024 | AKRO Akero Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -4,515 | $32.53 | $147k | 74,158 | Nov 1, 2024 |
| Nov 1, 2024 | AKRO Akero Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +15,485 | $21.10 | $327k | 89,643 | Nov 1, 2024 |
| Nov 1, 2024 | AKRO Akero Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -15,485 | $32.62 | $505k | 74,158 | Nov 1, 2024 |
| Oct 30, 2024 | AKRO Akero Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -4,515 | $0.00 | $0 | 57,266 | Nov 1, 2024 |
| Nov 1, 2024 | AKRO Akero Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -15,485 | $0.00 | $0 | 41,781 | Nov 1, 2024 |
| Oct 15, 2024 | AKRO Akero Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +14,825 | $0.62 | $9,117 | 90,119 | Oct 16, 2024 |
| Oct 15, 2024 | AKRO Akero Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -14,525 | $30.50 | $443k | 75,594 | Oct 16, 2024 |
| Oct 15, 2024 | AKRO Akero Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -300 | $30.93 | $9,278 | 75,294 | Oct 16, 2024 |
| Oct 14, 2024 | AKRO Akero Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +5,000 | $0.62 | $3,075 | 80,294 | Oct 16, 2024 |
| Oct 14, 2024 | AKRO Akero Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -6,136 | $30.03 | $184k | 74,158 | Oct 16, 2024 |
| Oct 15, 2024 | AKRO Akero Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -4,825 | $0.00 | $0 | 13,890 | Oct 16, 2024 |
| Oct 14, 2024 | AKRO Akero Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -5,000 | $0.00 | $0 | 8,890 | Oct 16, 2024 |
| Oct 15, 2024 | AKRO Akero Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -10,000 | $0.00 | $0 | 17,959 | Oct 16, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.